Can PSMA PET/CT Improve Prostate Cancer Staging and Care?

TOPLINE: A Danish study found that replacing the conventional fluorine-18 sodium fluoride (18F-NaF) PET/CT (“NaF” scan for short) with fluorine-18 prostate-specific membrane antigen-1007 (18F-PSMA) PET/CT (“PSMA” scan for short) for the staging of high-risk prostate cancer resulted in significant metastatic stage migration and the alteration of treatment plans in a significant number of patients…